AFB-DNA (TB-PCR) Detection – Body Fluid

This test detects DNA of Mycobacterium tuberculosis (MTB Complex) or Non-tuberculous bacteria (NTM/MOTT) in body fluids. If the result is MTB positive, the reflex test of Rifampicin resistance by Ultra CBNAAT is performed to determine if the MTB strain is resistant to Rifampicin, a critical drug used in TB treatment.

•  Diagnose infections caused by Mycobacterium tuberculosis or Non-tuberculous bacteria.
• Identify and treat drug-resistant strains of Mycobacterium tuberculosis.  Monitor the effectiveness of treatment for tuberculosis. 
• Detect and manage other infectious diseases.

This test is recommended for individuals who :

• Show symptoms of tuberculosis or other infectious diseases. 
• Have been exposed to someone with tuberculosis.
• Have a compromised immune system. 
• Need to monitor the effectiveness of treatment for tuberculosis or other infections.

Abnormal results may indicate the presence of Mycobacterium tuberculosis or Non-tuberculous bacteria in the body fluids.

During this test, 2ml of body fluid will be collected in a sterile leak-proof container to be sent to the lab for analysis. The test is painless and non-invasive.

To prepare for this test:

• Provide accurate clinical history, including symptoms and exposure to tuberculosis.
• Please reach out to your healthcare provider for any specific requirements.

• Ultra CBNAAT: To detect rifampicin resistance in Mycobacterium tuberculosis, if the initial test is positive for MTB Complex
•  Chest X-ray: To assess the presence and extent of lung involvement 
• Sputum culture: To identify specific strains of bacteria causing respiratory infections

TB PCR, TB DNA amplification.

Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis. It primarily affects the lungs but can also involve other parts of the body. TB spreads through the air when infected individuals cough or sneeze. Early diagnosis and treatment are crucial for effective management.